Associations of coronary artery calcification and carotid intima-media thickness with plasma concentrations of vascular calcification inhibitors in type 2 diabetic patients

被引:34
作者
Ishiyama, Masami [1 ]
Suzuki, Eiji [1 ,2 ]
Katsuda, Jun [1 ]
Murase, Hiroshi [1 ]
Tajima, Yoshitaka [1 ]
Horikawa, Yukio [1 ]
Goto, Shinobu [3 ]
Fujita, Tamio [3 ]
Takeda, Jun [1 ]
机构
[1] Gifu Univ, Sch Med, Dept Endocrinol & Diabet, Gifu 5011194, Japan
[2] Gifu Prefectural Gen Med Ctr, Dept Internal Med, Gifu 5008717, Japan
[3] Nagoya Mem Hosp, Dept Internal Med, Tenpaku Ku, Nagoya, Aichi 4688520, Japan
关键词
Coronary artery calcification; Carotid intima-media thickness; Bone-related peptide; Type; 2; diabetes; BEAM COMPUTED-TOMOGRAPHY; NECROSIS-FACTOR-ALPHA; SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; OSTEOPONTIN LEVELS; OSTEOPROTEGERIN LEVELS; RECEPTOR ACTIVATOR; ENDOTHELIAL-CELLS; DISEASE; PROGRESSION;
D O I
10.1016/j.diabres.2009.04.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vascular calcification is frequently accompanied by intima-media thickening, but the associations among these atherosclerotic features and bone-related peptides in diabetic patients are unclear. We enrolled 168 type 2 diabetic patients and 40 non-diabetic subjects consecutively admitted to our hospital. Mean intima-media thickness (mean-IMT) in common carotid arteries was measured by B-mode ultrasonography. Agatston coronary artery calcium score (CACS) was obtained using multidetector-row computed tomography (MDCT). Plasma bone-related peptides osteopontin and osteoprotegerin levels were measured. Diabetic patients had higher mean-IMT (p = 0.0002) and log(CACS + 1) (p < 0.0001) and similar bone-related peptides compared to non-diabetic subjects. in diabetic patients classified into tertiles according to their CACS levels, those with the highest scores showed the highest mean-IMT (p = 0.0004) and bone-related peptides (p < 0.05) among the groups. log(CACS + 1) and mean-IMT were associated (p < 0.0001) and were positively correlated with osteopontin (p < 0.01) and osteoprotegerin (p < 0.01) in diabetic patients. Multivariate analyses revealed that the significant independent determinants of log(CACS + 1) were age, duration of diabetes and osteopontin (p < 0.0001) and those of mean-IMT were age, hypertension, osteopontin and osteoprotegerin (p < 0.0001), respectively. We have demonstrated that vascular calcification in type 2 diabetic patients is frequently accompanied by intimamedia thickening, and osteopontin may act as a vascular calcification inhibitor by increasing intima-media thickness. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:189 / 196
页数:8
相关论文
共 46 条
  • [1] Influence of lipid-lowering therapy on the progression of coronary artery calcification - A prospective evaluation
    Achenbach, S
    Ropers, D
    Pohle, K
    Leber, A
    Thilo, C
    Knez, A
    Menendez, T
    Maeffert, R
    Kusus, M
    Regenfus, M
    Bickel, A
    Haberl, R
    Steinbeck, G
    Moshage, W
    Daniel, WG
    [J]. CIRCULATION, 2002, 106 (09) : 1077 - 1082
  • [2] QUANTIFICATION OF CORONARY-ARTERY CALCIUM USING ULTRAFAST COMPUTED-TOMOGRAPHY
    AGATSTON, AS
    JANOWITZ, WR
    HILDNER, FJ
    ZUSMER, NR
    VIAMONTE, M
    DETRANO, R
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 15 (04) : 827 - 832
  • [3] Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
  • [4] 2-S
  • [5] Standards of medical care in diabetes 2008
    不详
    [J]. DIABETES CARE, 2008, 31 : S12 - S54
  • [6] The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects
    Anand, DV
    Lahiri, A
    Lim, E
    Hopkins, D
    Corder, R
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (09) : 1850 - 1857
  • [7] [Anonymous], 2002, American Journal of Kidney Disease, V39, pS46, DOI DOI 10.1053/AJKD.2002.30943
  • [8] Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients
    Avignon, A
    Sultan, A
    Piot, C
    Elaerts, S
    Cristol, JP
    Dupuy, AM
    [J]. DIABETES CARE, 2005, 28 (09) : 2176 - 2180
  • [9] Diabetic neuropathies - A statement by the American Diabetes Association
    Boulton, AJM
    Vinik, AI
    Arezzo, JC
    Bril, V
    Feldman, EL
    Freeman, R
    Malik, RA
    Maser, RE
    Sosenko, JM
    Ziegler, D
    [J]. DIABETES CARE, 2005, 28 (04) : 956 - 962
  • [10] Receptor activator of NF-κB and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis
    Collin-Osdoby, P
    Rothe, L
    Anderson, F
    Nelson, M
    Maloney, W
    Osdoby, P
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (23) : 20659 - 20672